Project Grant R01NS136375

Award Date 6/1/24
Completion Date 4/30/29
Dollars Obligated $1.6M
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
Durham, NC 27715, USA
Similar Awards
The National Institute of Mental Health (NIMH) awarded a $1,111,187 Project Grant (CFDA 93.242 Mental Health Research Grants) to Georgetown University to investigate how a gene called CHD1, which is linked to autism spectrum disorder (ASD), impacts synaptic homeostatic plasticity - the mechanisms that stabilize synaptic function. The 5-year research project, which began in July 2024, will employ a multifaceted approach including genetics, electrophysiology, imaging, transcriptomics, and...
This Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), provides $195,896.00 to Emory University to investigate the impact of coding and non-coding mutations in the ARID1B gene on neuronal development and its link to neurodevelopmental disorders (NDDs). The primary objectives are to: 1) characterize ARID1B haploinsufficient mice at the single-cell level to...
This federal Project Grant award from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) will support research to investigate the role of de novo mutations in replication-independent histone genes and their link to rare pediatric neurodevelopmental disorders, known as "histonopathies." The $250,120 award, with a performance period from August 2024 to March 2027, will be provided...
This Project Grant award of $756,565.44 from the National Institutes of Health (NIH) National Institute of Child Health and Human Development (CFDA 93.865 - Child Health and Human Development Extramural Research) supports functional analysis research on histone modifier genes associated with autism spectrum disorders (ASD) in vertebrate development. The primary awardee is the University of California, Los Angeles (UCLA), which will leverage its extensive research capabilities, facilities, and...
This federal Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), supports research to elucidate the cellular and molecular mechanisms underlying autism spectrum disorder (ASD) pathology associated with Chromodomain Helicase DNA-Binding Protein 8 (CHD8) haploinsufficiency. The $164,992 award to the University of California, Davis, with a project period from...
This $443,121 federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports the University of California, Santa Cruz in conducting innovative research to understand dysregulated protein synthesis, or translation, in an autism spectrum disorder (ASD) model. The project aims to leverage cutting-edge cryo-electron microscopy (cryo-EM)...
This $216,000 federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program aims to elucidate the role of the CTCF protein in chromatin organization and transcriptional dynamics during neural differentiation. The primary awardee, the University of California, San Diego (UCSD), will utilize human pluripotent stem cells, neural progenitor cells, and...
This $267,310 Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), supports research to investigate the mechanisms by which the mutation-length CGG short tandem repeat (STR) in the FMR1 gene coordinates megabase-scale heterochromatin domains and their inter-chromosomal contacts in Fragile X Syndrome (FXS). The research aims to demonstrate how the mutation-length CGG...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $242,310 to Baylor College of Medicine to study the effects of the NR2E1 gene mutation on neurogenesis and its impact on human brain development and function. The research aims to: 1) assess how the I385T mutation in the NR2E1 gene affects its ability to interact with...
This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $2,049,254 to Cold Spring Harbor Laboratory to investigate the role of transient neuronal connectivity in the development and progression of Fragile X Syndrome, a leading genetic cause of autism. The research aims to elucidate the mechanisms by which sensory inputs and neuromodulatory signals establish and regulate transient neuronal circuits in...

CHROMATIN DYSREGULATION IN NEURODEVELOPMENTAL DISORDERS - PROJECT SUMMARY CHROMATIN-ASSOCIATED PROTEINS ARE A MAJOR CLASS OF GENES MUTATED IN AUTISM SPECTRUM DISORDER (ASD) AND INTELLECTUAL DISABILITY (ID). THESE GENETIC DATA INDICATE THE IMPORTANCE OF GENE REGULATION FOR BRAIN DEVELOPMENT, HOWEVER A SIGNIFICANT CHALLENGE FOR THE FIELD IS TO DETERMINE HOW DISRUPTIONS OF CHROMATIN REGULATORS MAY CONVERGE ON SPECIFIC BIOLOGICAL PROCESSES IN DEVELOPING NEURONS. TO ADDRESS THIS CHALLENGE, HERE WE FOCUS IN DETAIL ON THE BIOCHEMICAL AND CELLULAR MECHANISMS BY WHICH ID-ASSOCIATED FRAMESHIFT MUTATIONS IN THE LINKER HISTONE H1.4 RESULT IN IMPAIRED NEURONAL DEVELOPMENT. AS A HISTONE, H1.4 IS A DIRECT COMPONENT OF CHROMATIN; THUS, STUDYING HOW MUTATIONS IN THIS GENE IMPAIR NEURAL DEVELOPMENT OFFERS THE OPPORTUNITY TO GAIN SPECIFIC BIOCHEMICAL INSIGHT INTO MECHANISMS OF CHROMATIN REGULATION IN NEURONS. RAHMAN SYNDROME (RMNS) IS A RARE, GENETIC FORM OF ID CAUSED BY DE NOVO HETEROZYGOUS MUTATIONS IN H1-4, WHICH ENCODES HISTONE H1.4. ALL RMNS-ASSOCIATED MUTATIONS IN H1-4 ARE SMALL INSERTIONS OR DELETIONS THAT CREATE A SHARED C-TERMINAL FRAMESHIFT. GENETIC DATA INDICATE THAT THE MUTANT PROTEIN LIKELY FUNCTIONS IN A DOMINANT NEGATIVE OR NEOMORPHIC MANNER TO LEAD TO RMNS PHENOTYPES, BUT THE BIOCHEMICAL AND CELLULAR CONSEQUENCES OF EXPRESSING RMNS MUTANT HISTONE H1.4 ARE POORLY UNDERSTOOD. WE HAVE FOUND THAT EXPRESSING RMNS MUTANT HISTONE H1.4 IN RAT HIPPOCAMPAL NEURONS LEADS TO THE DISRUPTION OF SYNAPTIC GENE EXPRESSION AND NEURONAL FIRING. WE HYPOTHESIZE THAT RMNS MUTANT H1.4 DISRUPTS CHROMATIN ARCHITECTURE IN DIFFERENTIATING NEURONS TO IMPAIR GENE EXPRESSION PROGRAMS THAT ARE REQUIRED FOR SYNAPSE DEVELOPMENT AND NEURONAL FUNCTION. TO DETERMINE HOW THE RMNS MUTATION OF HISTONE H1.4 LEADS TO ABERRANT TRANSCRIPTION AND TO EVALUATE THE CONSEQUENCES FOR BRAIN DEVELOPMENT, WE WILL USE BOTH BIOCHEMICAL AND MOLECULAR GENETIC APPROACHES IN THE DEVELOPING MOUSE BRAIN AND IN HUMAN NEURONS. IN AIM 1, WE WILL BUILD A FOUNDATION FOR THESE STUDIES BY USING LEADING EDGE PROTEOMIC AND MOLECULAR GENETIC METHODS TO CHARACTERIZE THE EXPRESSION, REGULATION, AND CHROMATIN DISTRIBUTION OF HISTONE H1.4 OVER THE COURSE OF NEURONAL DIFFERENTIATION IN THE MOUSE. TO DETERMINE HOW RMNS MUTATIONS DISRUPT SYNAPTIC GENE EXPRESSION IN BRAIN DEVELOPMENT, IN AIM 2 WE WILL USE A NOVEL IN VIVO PROTEIN TAGGING STRATEGY TO IDENTIFY PROTEINS THAT INTERACT WITH WILDTYPE VERSUS RMNS MUTANT H1.4. FINALLY, TO DETERMINE HOW RMNS MUTATIONS DISRUPT CHROMATIN REGULATION, IN AIM 3 WE WILL STUDY GENERATE RMNS MUTANT H1.4 EXPRESSING IPSC- DERIVED NEURONS FOR BIOCHEMICAL HISTONE H1 PROTEOMICS AND GENE EXPRESSION ANALYSES. WE WILL THEN USE A NOVEL METHOD FOR LOW-INPUT THREE-DIMENSIONAL CHROMATIN CONFORMATION CAPTURE TO TEST THE HYPOTHESIS THAT RMNS MUTANT HISTONE H1.4 DISRUPTS HIGHER LEVEL CHROMATIN ARCHITECTURE. THESE STUDIES WILL ADVANCE KNOWLEDGE OF THE CAUSES OF BRAIN DEVELOPMENTAL ABNORMALITIES IN RMNS, AND THEY WILL CONTRIBUTE TO UNDERSTANDING OF THE SPECIFIC MECHANISMS OF LINKER HISTONE DEPENDENT CHROMATIN REGULATION THAT ARE KEY FOR NEURONAL MATURATION.

Posted 5/29/24, 12:00 AM